Penserra Capital Management’s QIAGEN NV QGENF Stock Holding History

Penserra Capital Management’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,440	Closed	-$32	–	1047
2016 Q1	$32	Buy	1,440 +480	+50%	+$11	﹤0.01%	370
2015 Q4	$27K	Buy	+960	New	+$27K	﹤0.01%	362

Other funds holding QGENF

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return

Penserra Capital Management's QGENF Position: Q2 2016 in Review

Penserra Capital Management sold out of QIAGEN NV (QGENF) in Q2 2016, closing a stake of 1,440 shares — an estimated $32 sold.

Penserra Capital Management first reported a position in QGENF in Q4 2015 and held it in 2 quarters. The position peaked at $27K in Q4 2015. 188 funds tracked by Wall St. Rank hold QGENF as of Q2 2016.

Penserra Capital Management reported no remaining QIAGEN NV position as of Q2 2016 after selling out during the quarter.
Penserra Capital Management sold 1,440 QIAGEN NV shares in Q2 2016, an estimated $32.
Penserra Capital Management first reported a position in QIAGEN NV in Q4 2015 and held it in 2 quarters.
Penserra Capital Management's QIAGEN NV position peaked at $27K in Q4 2015.
188 funds tracked by Wall St. Rank held QIAGEN NV as of Q2 2016.

Based on Penserra Capital Management's 13F filing for Q2 2016, filed 9 Aug 2016.